Correlation of Auscultatory Severity of Aortic Stenosis With Trans Thoracic Echocardiography (CASSETTE)
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/30/2013 |
| Start Date: | May 2012 |
| Contact: | William E Bennett, MD |
| Email: | william.bennett5@med.navy.mil |
| Phone: | 619-532-7400 |
Correlation of Auscultatory Severity of Aortic Stenosis With Trans Thoracic Echocardiography
According to the 2006 ACC/AHA practice guidelines for valvular heart disease, patients with
asymptomatic aortic stenosis(AS) should have screening transthoracic echocardiograms (TTE)
performed annually for severe disease, every 1-2 years for moderate disease and every 3-5
years for mild disease. This results in a multitude of screening studies in the
investigators patient population. 3M has developed a new stethoscope and phonocardiography
software capable of identifying the peak intensity of the AS murmur and tracking it as it
moves towards the second heart sound potentially indicating increasing severity of disease.
Currently there exists no data to demonstrate that the aortic stenosis acceleration index
(ASAI) correlates to disease severity or progression of disease. The ASAI measures the
timing of the peak intensity of the systolic murmur and compares it to the total time in
systole (S2-x/s2-s1) where s1 is the first heart sound; S2 is the second heart sound and x
with the time between S1 and the peak intensity of the murmur. In this study the
investigators propose to correlate the ASAI to standard TTE measurements of aortic stenosis
severity.
Inclusion Criteria:
1. Male and female subjects 18 years of age and older.
2. Subjects must have asymptomatic Aortic Stenosis documented by prior echocardiographic
examination.
3. Subjects must be able to sit for auscultation examination.
4. Subject must be able to complete a TTE .
5. Subjects must voluntarily agree to participate in the study and sign the informed
consent and healthcare information authorization forms.
Exclusion Criteria:
1. Subjects with significant additional valvular heart disease.
2. Subjects with unrecordable heart sounds.
3. Subjects with known or who may have been previously diagnosed with congenital heart
disease.
4. Subjects with atrial fibrillation.
5. Subjects with history of cardiac surgery.
6. Subjects who have conditions which the researcher feels may limit the recordability
of the heart sounds or the accuracy of the echocardiogram.
We found this trial at
1
site
Naval Medical Center - San Diego We are the largest and most comprehensive military healthcare...
Click here to add this to my saved trials
